DrugPatentWatch Database Preview
Auranofin - Generic Drug Details
What are the generic sources for auranofin and what is the scope of freedom to operate?
Auranofin
is the generic ingredient in one branded drug marketed by Sebela Ireland Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for auranofin. One supplier is listed for this compound.
Summary for auranofin
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 7 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 19 |
| Clinical Trials: | 13 |
| Patent Applications: | 3 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for auranofin |
| DailyMed Link: | auranofin at DailyMed |
Recent Clinical Trials for auranofin
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 2 |
| Mayo Clinic | Phase 2 |
| The Aurum Institute NPC | Phase 2 |
Recent Litigation for auranofin
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| MERCK SHARP & DOHME CORP. v. APOTEX INC. | 2009-12-18 |
Medical Subject Heading (MeSH) Categories for auranofin
Synonyms for auranofin
| (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate |
| (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold2,3,4,6-tetraacetate |
| (2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-kappaS(1))(triethylphosphine)gold |
| [1-(Thio-|ES)-|A-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold |
| 2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold |
| 34031-32-8 |
| AC1OCFGC |
| Auranofina |
| Auranofine |
| Auranofinum |
| Auroafen |
| BDBM50153291 |
| CHEBI:2922 |
| CHEMBL1366 |
| DB00995 |
| gold(+1) cation; (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane |
| gold(1+); (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane |
| GTPL6306 |
| Ridaura |
| Ridauran |
| SCHEMBL5188854 |
| SK-39162 |
| SK&F-39162 |
| Triethylphosphine gold |
US Patents and Regulatory Information for auranofin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for auranofin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | Start Trial | Start Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | Start Trial | Start Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | Start Trial | Start Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | Start Trial | Start Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
